Dedicated Booth in the exibition area to present the new Liaison MDX and PCR technology associated.
Diasorin launches its first molecular test with the new Business Division, DiaSorin Molecular: the new Simplexa® C. Difficile Direct molecular test.
Oral presentation 8.30- 10 am 18 October 2016
DiaSorin S.p.A. is pleased to announce the launch of the Iam AML1-ETO assay on its LIAISON® IAM analyzer.
DIASORIN HAS COMPLETED ACQUISITION OF THE FOCUS DIAGNOSTICS’ MOLECULAR AND IMMUNOASSAY PRODUCT BUSINESS FROM QUEST DIAGNOSTICS